Embolization Coils Market Share

North American Market Forecast

North America industry is predicted to dominate majority revenue share of 41% by 2037, impelled by growing spending in healthcare. As a result, more advanced smart diagnostic and monitoring medical device such as embolization coils are being developed in the region. This has increased the adoption rates of these coils as they have become more accessible to people and are easily available in hospitals and clinics. In 2021, the United States spent over 2% more on health care.

European Market Statistics

The Europe embolization coils market is estimated to be the second largest, during the forecast timeframe led by increasing cases of cardiac aneurysm. This is expected to increase the demand for an embolization coils in the region as it is used to treat aneurysms, which involves filling the sac with material to prevent bleeding and closing it off. Each year, more than 14,000 Americans and over 25,000 Europeans are diagnosed with ascending thoracic aortic aneurysm (ATAA).

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of embolization coils is assessed at USD 2.48 billion.

The embolization coils market size was valued at USD 2.25 billion in 2024 and is expected to reach USD 4.98 billion by 2037, registering around 6.3% CAGR during the forecast period i.e., between 2025-2037. Growing cases of cancer across the globe and the growing usage in hematuria management will boost the market growth.

North America industry is predicted to dominate majority revenue share of 41% by 2037, impelled by growing spending in healthcare.

The major players in the market are Boston Scientific Corporation, DePuy Synthes, Medtronic, St. Jude Medical, Sirtex, Cook Medical, Cordis Corporation, Johnson & Johnson Services, Inc., Shape Memory Medical, Inc.

Embolization Coils Market Share